Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cytomegalovirus Infections, Heart Transplantation”

11 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 11 of 11 results

Testing effectiveness (Phase 2)Looking for participantsNCT06066957
What this trial is testing

Open Label Trial of Oral Letermovir for CMV Prophylaxis in Thoracic Transplant Recipients

Who this might be right for
Cytomegalovirus InfectionsTransplant-Related Disorder
University of Pennsylvania 80
Not applicableLooking for participantsNCT06341543
What this trial is testing

Quantiferon CMV to Identify Treatment Need for Asymptomatic CMV Infection After Solid Organ Transplant (QUANTIFOT)

Who this might be right for
Cytomegalovirus InfectionsHeart TransplantationKidney Transplantation+2 more
University Hospital, Grenoble 288
Early research (Phase 1)Study completedNCT01165580
What this trial is testing

A Study on the Pharmacokinetics and Safety of Valcyte (Valganciclovir) in Pediatric Heart Transplant Recipients Less Than 4 Months of Age

Who this might be right for
Cytomegalovirus Infections, Heart Transplantation
Hoffmann-La Roche 17
Post-approval studies (Phase 4)Study completedNCT04904614
What this trial is testing

Letermovir Use in Heart Transplant Recipients

Who this might be right for
Cytomegalovirus DiseaseCytomegalovirus InfectionsHeart Transplant Infection+2 more
Tufts Medical Center 32
Post-approval studies (Phase 4)Study completedNCT00299221
What this trial is testing

Safety Outcomes of Lower Immunosuppression Versus Traditional Immunosuppression in Heart Transplant Recipients

Who this might be right for
Immunosuppression
Newark Beth Israel Medical Center 150
Not applicableStudy completedNCT00436384
What this trial is testing

Cell Mediated Immunity and the Prediction of CMV Infection In Solid Organ Transplant Recipients

Who this might be right for
Transplant
University Health Network, Toronto 150
Large-scale testing (Phase 3)UnknownNCT00966836
What this trial is testing

Prevention of Transplant Atherosclerosis With Everolimus and Anti-cytomegalovirus Therapy

Who this might be right for
Heart TransplantationCardiac Allograft VasculopathyCytomegalovirus Infection
University of Bologna 100
Not applicableActive Not RecruitingNCT03924219
What this trial is testing

CMV T Cell Immunity in Pediatric Solid Organ Transplant Recipients

Who this might be right for
Heart Transplant InfectionKidney Transplant InfectionLiver Transplant Infection+1 more
Vanderbilt University Medical Center 120
Not applicableStudy completedNCT00817908
What this trial is testing

Quantiferon - Cytomegalovirus (CMV) and the Prediction of CMV Infection In High Risk Solid Organ Transplant Recipients

Who this might be right for
Cytomegalovirus Infection
University of Alberta 131
Post-approval studies (Phase 4)UnknownNCT04278547
What this trial is testing

Multicenter Clinical Trial to Evaluate the Efficacy of a Preventive Strategy Against CMV Infection in Heart Transplant Patients, Based on the Specific T Cells Response

Who this might be right for
Heart Transplant InfectionCMV Infection
Hospital Universitari de Bellvitge 188
Not applicableStudy completedNCT01558037
What this trial is testing

Cell Mediated Immunity With Risk of Cytomegalovirus (CMV) in Solid Organ Transplant Recipients

Who this might be right for
Awaiting Organ TransplantInfection in Solid Organ Transplant Recipients
Michael Ison 113